Enterococcal isolates carrying the novel oxazolidinone resistance gene optrA from hospitals in Zhejiang, Guangdong, and Henan, China, 2010-2014

Clinical Microbiology and Infection

Volumn 21, Issue 12, 2015, Pages 1095.e1-1095.e4

  Cai, J ^a   Wang, Y ^b   Schwarz, S ^c   Lv, H ^d   Li, Y ^e   Liao, K ^f   Yu, S ^g   Zhao, K ^h   Gu, D ^a   Wang, X ^a   Zhang, R ^a   Shen, J ^b  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

^c FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^d ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^e HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^f THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^g TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

^h Cixi Hospital Affiliated with Wenzhou Medical University   (China)

Author keywords

Antimicrobial resistance; Enterococci; Linezolid; Molecular epidemiology; Nosocomial infection; Phenicols; Tedizolid

Indexed keywords

AMPICILLIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; DAPTOMYCIN; FLORFENICOL; LINEZOLID; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; TEDIZOLID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHINA; CLINICAL ARTICLE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; ENTEROCOCCUS THAILANDICUS; FEMALE; GENE; HETEROZYGOTE; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIDDLE AGED; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; OPTRA GENE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SPECIES IDENTIFICATION; VERY ELDERLY; YOUNG ADULT; BACTERIAL GENE; BACTERIUM IDENTIFICATION; CROSS INFECTION; GENETICS; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CHINA; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; FEMALE; GENES, BACTERIAL; HOSPITALS; HUMANS; MALE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; OXAZOLIDINONES; YOUNG ADULT;

EID: 84945539738     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.08.007     Document Type: Article

References (15)

1. Wilson D.N., Schluenzen F., Harms J.M., Starosta A.L., Connell S.R., Fucini P. The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning. Proc Natl Acad Sci USA 2008, 105:13339-13344.
2. Moellering R.C. Tedizolid: a novel oxazolidinone for Gram-positive infections. Clin Infect Dis 2014, 58(Suppl. 1):S1-S3.
3. Johnson A.P., Tysall L., Stockdale M.V., Woodford N., Kaufmann M.E., Warner M., et al. Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit. Eur J Clin Microbiol Infect Dis 2002, 21:751-754.
4. Mendes R.E., Deshpande L.M., Jones R.N. Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms. Drug Resist Updat 2014, 17:1-12.
5. Shen J., Wang Y., Schwarz S. Presence and dissemination of the multiresistance gene cfr in Gram-positive and Gram-negative bacteria. J Antimicrob Chemother 2013, 68:1697-1706.
6. Long K.S., Poehlsgaard J., Kehrenberg C., Schwarz S., Vester B. The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics. Antimicrob Agents Chemother 2006, 50:2500-2505.
7. Wang Y., Lv Y., Cai J.C., Schwarz S., Cui L., Hu Z., et al. A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin. J Antimicrob Chemother 2015, 70:2182-2190.
8. Itani K.M., Shorr A.F. FDA guidance for ABSSSI trials: implications for conducting and interpreting clinical trials. Clin Infect Dis 2014, 58(Suppl. 1):S4-S9.
9. Locke J.B., Zurenko G.E., Shaw K.J., Bartizal K. Tedizolid for the management of human infections: in vitro characteristics. Clin Infect Dis 2014, 58(Suppl. 1):S35-S42.
10. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing 2015, 25th informational supplement, M100-S25, CLSI, Wayne, PA.
11. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard 2015, M07-A10, CLSI, Wayne, PA. 10th ed.
12. Saeedi B., Hallgren A., Jonasson J., Nilsson L.E., Hanberger H., Isaksson B. Modified pulsed-field gel electrophoresis protocol for typing of enterococci. APMIS 2002, 110:869-874.
13. Ruiz-Garbajosa P., Bonten M.J., Robinson D.A., Top J., Nallapareddy S.R., Torres C., et al. Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in a background of high rates of recombination. J Clin Microbiol 2006, 44:2220-2228.
14. Homan W.L., Tribe D., Poznanski S., Li M., Hogg G., Spalburg E., et al. Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol 2002, 40:1963-1971.
15. Brown S.D., Traczewski M.M. Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges. Antimicrob Agents Chemother 2010, 54:2063-2069.